Status:
WITHDRAWN
Quantitative Magnetic Resonance Imaging in Biliary Disease: Health Economics Study
Lead Sponsor:
Perspectum
Collaborating Sponsors:
University of Birmingham
Conditions:
Primary Sclerosing Cholangitis
PSC
Eligibility:
All Genders
18+ years
Brief Summary
This is a health economic study on using quantitative magnetic resonance imaging in biliary disease. It is an observational study aiming to recruit 40 patients with Primary Sclerosing Cholangitis (PSC...
Detailed Description
Primary sclerosing cholangitis (PSC) is the greatest unmet need in modern liver medicine. There continue to be no direct bio-markers for the diagnosis and monitoring of biliary diseases such as PSC, c...
Eligibility Criteria
Inclusion
- Adult patients aged 18 years or over
- Patient due to attend the hepatology clinic for PSC diagnostics/review
- Participant is willing and able to give informed consent
Exclusion
- The participants may not enter the study if they have any contraindication to magnetic resonance imaging (including pregnancy, extensive tattoos, pacemaker, shrapnel injury, severe claustrophobia).
- Any other cause, including a significant disease or disorder which, in the opinion of the investigator, may either put the participant at risk because of participation in the study, or may influence the result of the study, or the participant's ability to participate in the study
Key Trial Info
Start Date :
December 21 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04015310
Start Date
December 21 2020
End Date
March 31 2021
Last Update
July 21 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.